CDMO - Avid Bioservices, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Avid Bioservices, Inc.

2642 Michelle Drive
Suite 200
Tustin, CA 92780
United States
714 508 6100
https://www.avidbio.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees321

Key Executives

NameTitlePayExercisedYear Born
Mr. Nicholas Stewart Green B.Sc., MBAPres, CEO & Director1.54MN/A1965
Mr. Daniel R. HartChief Financial Officer801.11k11.71k1973
Mr. Mark R. Ziebell J.D.VP, Gen. Counsel & Corp. Sec.711.45k684.79k1964
Mr. Richard RichieriChief Operations OfficerN/AN/A1965
Ms. Oksana LukashVP of PeopleN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Corporate Governance

Avid Bioservices, Inc.’s ISS Governance QualityScore as of May 1, 2023 is 3. The pillar scores are Audit: 8; Board: 2; Shareholder Rights: 4; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.